Antibiotice Iasi, Set To Near EUR100M In Revenue In 2016

05.01.2014 By Ioana David

Antibiotice Iasi (ATB.RO) plans to boost revenue by stepping up exports and launching new products. The company ranks 11th among the biggest players on the Romanian pharmaceutical market.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Read Also:
Antibiotice Sees 2014 Net Profit Up 6% To RON30.5M
Antibiotice Posts 6.3% Higher Profit At RON28.8M In 2013
Antibiotice Iasi Aims To Double Export Revenue In 2016-2020
Keywords:
Antibiotice Iasi
, pharmaceutical market
Comment

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.